VARODENT
ActiveVARODENT has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €455k and a net result of €28k. Equity remains stable across the filed fiscal years (±1.2% per year). Its solvency ranks better than 95% of 641 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
91
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▲+5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 90.16 against 43.4 in 2024; short-term debt: 1.1% and cash: 69% of total assets), and 1.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
98.7%
Return on assets
6.2%
Age of the figures
12 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 23-03-2026, 38 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
38 d early
2024
37 d early
2023
43 d early
2022
41 d early
2021
40 d early
2020
38 d early
2019
31 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€455k▲ 6.7%
2024 · €426k
2018: €388k
2019: €431k
2020: €468k
2021: €523k
2022: €369k
2023: €433k
2024: €426k
2018 → 2025
Total assets
€460k▲ 5.5%
2024 · €437k
2018: €395k
2019: €450k
2020: €474k
2021: €530k
2022: €461k
2023: €439k
2024: €437k
2018 → 2025
Net result
€28k▼ 51.5%
2024 · €59k
2018: €21k
2019: €43k
2020: €37k
2021: €55k
2022: €49k
2023: €64k
2024: €59k
2018 → 2025
Working capital
€440k▲ 10.0%
2024 · €400k
2018: €344k
2019: €405k
2020: €461k
2021: €515k
2022: €323k
2023: €395k
2024: €400k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€523k-€369k▼ 29.6%€433k▲ 17.3%€426k▼ 1.5%€455k▲ 6.7%
Operating result€70k-€73k▲ 3.5%€88k▲ 20.8%€72k▼ 18.2%€35k▼ 51.5%
Net result€55k-€49k▼ 12.3%€64k▲ 31.4%€59k▼ 8.1%€28k▼ 51.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 51% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €460k
Fixed assets
€15k▼ 43.0%
Current assets
€445k▲ 8.6%
Equity and liabilities €460k
Equity
€455k▲ 6.7%
Debt
€6k▼ 44.6%
The debt ratio falls from 2.4% to 1.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€48k▼
2024 · €84k
Cash flow
€41k▼
2024 · €71k
Solvency
98.7%▲
2024 · 97.6%
Current ratio
90.16▲
2024 · 43.40
Quick ratio
86.96▲
2024 · 41.74
Debt / equity
0.01▼
2024 · 0.02
ROE
6.3%▼
2024 · 13.8%
ROA
6.2%▼
2024 · 13.4%
Interest coverage
30.87▲
2024 · -13.80
Debt
€6k▼
2024 · €10k
Debt ≤ 1 year
€5k▼
2024 · €9k
Income taxes
€11k▼
2024 · €21k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€437k€460k▲
Fixed assets21/28€27k€15k▼
Tangible fixed assets22/27€27k€15k▼
Plant, machinery and equipment23€8k€5k▼
Furniture and vehicles24€19k€11k▼
Current assets29/58€410k€445k▲
Stocks and contracts in progress3€16k€16k▲
Stocks30/36€16k€16k▲
Amounts receivable within one year40/41€24k€11k▼
Trade receivables40€24k€5k▼
Other amounts receivable41€240€6k▲
Current investments50/53€95k€99k▲
Cash at bank and in hand54/58€276k€318k▲
Deferred charges and accrued income490/1€7€3k▲
Equity and liabilities
Total equity and liabilities10/49€437k€460k▲
Equity10/15€426k€455k▲
Contributions10/11€19k€19k=
Reserves13€408k€436k▲
Distributable reserves133€408k€436k▲
Amounts payable17/49€10k€6k▼
Amounts payable within one year42/48€9k€5k▼
Trade debts44€4k€941▼
Suppliers440/4€4k€941▼
Taxes, remuneration and social security45€3k€1k▼
Taxes450/3€3k€1k▼
Other amounts payable47/48€3k€3k▼
Accrued charges and deferred income492/3€962€831▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€13k▲
Other operating charges640/8€542€568▲
Gross operating margin9900€85k€48k▼
Operating profit (loss)9901€72k€35k▼
Financial income75/76B€1k€6k▲
Recurring financial income75€1k€6k▲
Financial charges65/66B€-6k€2k▲
Recurring financial charges65€-6k€2k▲
Profit (loss) for the period before taxes9903€79k€39k▼
Income taxes67/77€21k€11k▼
Profit (loss) for the period9904€59k€28k▼
Profit (loss) for the period to be appropriated9905€59k€28k▼
Appropriation of the result
Profit (loss) to be appropriated9906€59k€28k▼
Transfer from equity791/2€65k-
Transfer to equity691/2€59k€28k▼
To other reserves6921€59k€28k▼
Profit to be distributed694/7€65k-
Return on contributions (dividend)694€65k-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Liquidity doublescurrent ratio 90.16
Current ratio from 43.40 to 90.16; short-term debt falls from €9k to €5k.
24-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
18-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Highest result since 2018net €64k ▲31.4%
Operating result €88k, net result €64k, both a record.
30-09
Financial
Liquidity times 16current ratio 72.34
Current ratio from 4.52 to 72.34; short-term debt falls from €92k to €6k.
20-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
21-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Equity above €500kEq €523k ▲11.8%
4 profitable years in a row build equity to €523k.
23-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-09
Financial
Liquidity triplescurrent ratio 73.89
Current ratio from 21.74 to 73.89; short-term debt falls from €20k to €6k.
30-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
28-03
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
28-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
20-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rotselaar · 1 establishment unit since 2006
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Leuvensebaan 863110 RotselaarGround area
960 m²
Building footprint
135 m²
Volume, LiDAR
810 m³
Parcel 24094C0188/00_000, Flanders · tallest building 8.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Varodent
since 20062.152.627.562
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24094C0188/00_000 | Flanders | 960 m² | 1 · 135 m² | 8.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
967600C51XR4GZC7J021
Similar companies · same sector, comparable size
MERIDIAN BIOSCIENCE EUROPE
BE 0408.081.968
Braine-l'Alleud · Eq €455k
BOP mon artisan
BE 0840.273.485
Ciney · Eq €456k
2INGIS
BE 0444.433.511
Brussel · Eq €456k
CairnSurgical Europe
BE 0775.905.770
Leuven · Eq €458k
Adler Ortho Belgium
BE 0875.339.282
Brussel · Eq €459k
Of 1,250 companies in sector 32500 we hold annual accounts for 695. 502 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-03-2006
Fiscal year end30-09
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
33103
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.